JPRN-UMIN000007925招募中2 期
Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the stomach cancer patient - Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the stomach cancer patient
Osaka University Clinical Research Group for Gastroenterological Study0 个研究点目标入组 1,000 人开始时间: 2012年5月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Synchronous or metachronous (within 5 years) malignancies
研究者
相似试验
招募中
2 期
Examination of the usefulness as the tumor marker of the NY-ESO-1 antibody titer in the esophageal cancer patientesophageal cancerJPRN-UMIN000008997Osaka University,Graduate School of Medicine, Department of Gastroenterological Surgery400
招募中
不适用
Search of a new tumor marker and examination of usefulness by multi-institutinal studyBreast cancer, Thyroid cancer, Esophageal cancer, Gastric cancer, Colon cancer, Liver cancer, Biliary cancer, Pancreatic cancerJPRN-UMIN000014530Toho Univerisity300
已完成
不适用
Circulating tumor cells as a diagnostic marker for pancreatico-biliary malignanciesPancreatico-biliary malignanciesJPRN-UMIN000029808Fukushima Medical University School of Medicine22
尚未招募
2 期
A clinical study to assess the Feasibility Study of the Tumour Specific Electroporation (TSE) Technique in Patients with Locally Advanced or Recurrent Head & Neck CancerCTRI/2022/09/045315India Sweden Healthcare Innovation Centre
招募中
Unknown
Biomarker discovery research for malignant tumors using SCRUM-Japan GI/MONSTAR-SCREEN integrated databaseSolid MalignanciesJPRN-UMIN000049334ational Cancer Center Hospital East27,500